Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care

NCT04541381 is registered in ClinicalTrials.gov with University of Chicago as lead sponsor.

NCT NCT04541381
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04541381 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care
Lead sponsor
University of Chicago
Phase
Not applicable
Overall status
Suspended
Start date
February 7, 2022
Completion date
March 31, 2028
Enrollment
860 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, dihydropyrimidine dehydrogenase deficiency, gastrointestinal cancer, head and neck cancer, ugt1a1 gene mutation